KLK3 and prostate cancer: The role of serum PSA as a biomarker for prostate cancer diagnosis, prognosis, treatment monitoring as well as survival evaluation is well established 30–32; thus, the decline in PSA noted in this study was expected after orchidectomy due to loss of androgen trophism 33.